~~<i id='CA2E9968D9'><strike id='CA2E9968D9'><tt id='CA2E9968D9'><pre id='CA2E9968D9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：hotspot 2025-10-01 23:01:48 - browse：39213

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Restaurant meals are packed with calories, and we still keep eating them

explore

focus

entertainment

leisure time

focus

explore

KathiKolb,aRhodeIslandphysicaltherapist,saysshe’sfrustratedthatfewerthanhalfofeligiblebreastcancerpa

WSS

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Restaurant meals are packed with calories, and we still keep eating them

St. Louis police protesters begin picking up checks in $4.9 million settlement

‘Oppenheimer’ and the risks of AI in health care

NIH launches clinical trials and new research office for long Covid

'Brian's Song' at 50 still offers lessons about cancer for today

hotspot

fashion

explore

In Memoriam: Notable people who died in 2023

St. Louis police protesters begin picking up checks in $4.9 million settlement

Apple is now the first public company to be valued at $3 trillion

Adults seen as increasingly susceptible to measles

Cancer drug shortages should be causing more outrage

It was time to plan for my old age. If only I could stop crying

Jerome Adams on the need for new antivirals for Covid

Mega Millions pot grows to $1.25 billion after no winner

In Memoriam: Notable people who died in 2023

National panel will explore requiring free Covid tests

focus

Sage hopes for a blockbuster in antidepressant now before FDA

What the airline industry can learn from medicine

Mega Millions pot grows to $1.25 billion after no winner

Paxlovid rebound happens. Why and to whom are still a mystery

Sweden knocks USA out of World Cup in penalty kicks

St. Louis police protesters begin picking up checks in $4.9 million settlement

entertainment

leisure time

focus

explore